The Antibody Drug Conjugates (ADC) market was valued at USD 10.77 Billion in 2024 and is expected to reach USD 34.32 Billion by 2032, growing at a CAGR of 15.59% (2024-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.